• 1. Department of Gastrointestinal Surgery, People’s Hospital of Henan University, Kaifeng, Henan 475000, P. R. China;
  • 2. Department of Gastrointestinal Surgery, People’s Hospital of Zhengzhou University, Zhengzhou 450003, P. R. China;
  • 3. Department of Gastrointestinal Surgery, Henan Provincial People’s Hospital, Zhengzhou 450003, P. R. China;
SUN Peichun, Email: sunpeichun@163.com
Export PDF Favorites Scan Get Citation

Objective  To evaluate the clinical short-term efficacy and safety of application of glucocorticoids (GCs) before major abdominal surgery. Methods  The randomized controlled trials (RCTs) on application of GCs before major elective abdominal surgery were systematically and comprehensively searched in Medline (1966–2022), Embase (1947–2022), Web of Science, and PubMed databases, and systematic review and meta-analysis of the included studies were performed to explore the effects of application of GCs before major abdominal surgery on postoperative complication, hospital stay, and serum interleukin-6 level. Results  Nineteen moderate quality RCTs with 1 535 patients were finally included in the analysis. Preoperative application of GCs reduced postoperative IL-6 level [MD=–51.00, 95%CI (–62.36, –39.63), P<0.001], reduced postoperative complications [OR=0.53, 95%CI (0.35, 0.81), P=0.003], shorten hospital stay [MD=–0.64, 95%CI (–1.04, –0.24), P=0.002], and reduced the occurrence of infectious complications [OR=0.50, 95%CI (0.36, 0.70), P<0.01]. However, there were no statistically significant difference in incidence of anastomotic leakage [OR=1.15, 95%CI (0.43, 3.04), P=0.780] and bile leakage [OR=1.95, 95%CI (0.76, 5.00), P=0.170]. Conclusion  Preoperative application of GCs can reduce the level of IL-6, reduce complications after major abdominal surgery and shorten postoperative hospital stay.

Citation: YANG Jingshu, DU Shuxiang, LIANG Yanxu, ZHANG Lulu, WANG Tao, WU Gang, SUN Peichun. Risks and benefits of application of preoperative glucocorticoid in major abdominal surgery: a systematic review. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2023, 30(5): 595-602. doi: 10.7507/1007-9424.202212033 Copy

  • Previous Article

    Usage of proton pump inhibitors is associated with pancreatic cancer: a systematicreview and meta-analysis
  • Next Article

    6例完全3D腹腔镜下肝门部胆管癌根治术围手术期治疗效果总结